#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kaposi's sarcoma Hereditary optic atrophy Malformation venous Proteus syndrome Oesophageal atresia Factor VIII deficiency Chronic inflammatory demyelinating polyradiculoneuropathy Hyperinsulinism Epstein-Barr virus infection Neuroendocrine carcinoma Chronic graft versus host disease in liver HER2 mutant non-small cell lung cancer Small for dates baby Cystic fibrosis respiratory infection suppression Transitional cell cancer of the renal pelvis and ureter More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Trials in Disease Indolent systemic mastocytosis – Trials in Disease Rhabdomyosarcoma recurrent – Treatment CADASIL – Life with Disease Soft tissue sarcoma – Life with Disease Retinitis pigmentosa Ornithine transcarbamoylase deficiency – Life with Disease Hairy cell leukaemia – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Osteosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivospemin Treg02 Formoterol Fumarate Dihydrate Zidesamtinib Cart 19/22 T Cells Odevixibat Lerodalcibep Clavulanic Acid Ly3541860 Glucose Monohydrate Ph. Eur. Bevacizumab Omeprazole Kan-101 Tovinontrine Dersimelagon Phosphate RNMB3 Vortioxetine Progesterone FRUQUINTINIB Yttrium-90 More therapies…

    Learn about Your Condition

    Renal disorder Agitation postoperative Glioma Immune-mediated myositis HER2 positive breast cancer Heparin resistance Coeliac disease Ewing's sarcoma Idiopathic pulmonary fibrosis Acute leukaemia Rheumatoid arthritis Aortic aneurysm Hepatic neoplasm Dermatitis atopic Leukocyte adhesion deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diffuse large B-cell lymphoma

  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pegfilgrastim
    • Acalabrutinib
    • Cyclophosphamide
    Germany Greece

  • Study of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Epcoritamab
    Germany

  • Study on the Effectiveness and Safety of Cytarabine, Tafasitamab, and Lenalidomide for Patients with Relapsed Diffuse Large B-Cell Lymphoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell unclassifiable lymphoma high grade
    • Diffuse large B-cell lymphoma stage I
    • Diffuse large B-cell lymphoma stage II
    Investigated Drugs:
    • Tafasitamab
    • Axicabtagene Ciloleucel
    • Bendamustine Hydrochloride
    Poland

  • Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Odronextamab
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Germany Hungary Italy +4

  • Study of CD19-CAR_Lenti, Fludarabine, and Cyclophosphamide in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia or Aggressive B-Cell Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary mediastinal large B-cell lymphoma
    • Diffuse large B-cell lymphoma
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Fludarabine Phosphate
    • Cyclophosphamide
    Italy

  • Study on the Effectiveness and Safety of Ibrutinib with Rituximab-CHOP for Untreated Patients with Diffuse Large B-cell Lymphoma at High Risk

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ibrutinib
    • Vinorelbine
    • Cyclophosphamide
    Italy
Previous Page
1 2 3 4 5 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!